India's Serum Institute says prioritising domestic vaccine needs, asks for patience

0:00
play article
Subscribers can listen to this article
  • Vaccine producer the Serum Institute of India asked for patience in producing Covid-19 vaccines.
  • Chief executive Adar Poonawalla said company was asked to prioritise Indian needs.
  • The company is expected to deliver Covishield by March.


Serum Institute of India (SII), the world's biggest vaccine maker by volume, on Sunday asked for patience from foreign governments awaiting their supply of Covid-19 shots, saying it had been directed to prioritise India's requirements.

"...I humbly request you to please be patient," SII's Chief Executive Adar Poonawalla said in a tweet, adding the company "has been directed to prioritise the huge needs of India and along with that balance the needs of the rest of the world".

"We are trying our best," Poonawalla said.

LIVE | All the latest coronavirus and lockdown updates

Based in the western Indian city of Pune, the company is manufacturing the Oxford University/AstraZeneca Covid-19 vaccine, one of the two shots that India is using to initially vaccinate some 300 million people as part of a national inoculation drive.

Many low-and middle-income countries, ranging from Bangladesh to Brazil, are depending on SII's AstraZeneca vaccine, branded Covishield by the Indian company.

But demand is growing, including from Western countries like Canada, where Poonawalla has promised to deliver the Covishield vaccine in March.

Criticism

Britain's drug regulator is also auditing manufacturing processes at SII, potentially paving the way for the Covishield vaccine to be shipped from there to the UK and other countries.

Indian Prime Minister Narendra Modi's government has come under criticism for the slow take-off of its vaccination drive but health authorities are preparing to expand the number of inoculation substantially in coming weeks.

India has vaccinated around 11 million people since mid-January.

With more than 10.9 million confirmed infections, India has the world's second highest number of Covid-19 cases, behind only the US.

The country is currently reporting around 12 000 new infections on average each day, a fraction of its peak from last September, according to a Reuters analysis.

But federal health authorities on Sunday said they had written to some states that are currently seeing a surge in cases, asking them to improve overall testing, surveillance and monitoring of Covid-19 mutations.

Did you know you can comment on this article? Subscribe to News24 and add your voice to the conversation.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
When a Covid-19 vaccine for under 16's becomes available, will you be taking your children to get it?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, immediately!
38% - 2913 votes
I'll wait to see how others respond
26% - 2022 votes
No, I don't think they need it
36% - 2832 votes
Vote
ZAR/USD
14.96
(+0.52)
ZAR/GBP
20.85
(+0.72)
ZAR/EUR
18.02
(+0.85)
ZAR/AUD
11.63
(+0.21)
ZAR/JPY
0.14
(+0.66)
Gold
1734.42
(-0.22)
Silver
26.84
(+0.29)
Platinum
1203.26
(+0.51)
Brent Crude
64.90
(0.00)
Palladium
2361.01
(+1.09)
All Share
67536.96
(+2.12)
Top 40
62107.04
(+2.23)
Financial 15
12456.31
(+2.10)
Industrial 25
88082.08
(+2.25)
Resource 10
68969.71
(+2.24)
All JSE data delayed by at least 15 minutes morningstar logo